Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Damiano Rondelli, MD
Myeloproliferative Disorders-Research Consortium
Study Chair - Giovanni Barosi, MD
Myeloproliferative Disorders-Research Consortium
Study Chair - John Mascarenhas, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Ospedali Riuniti Di Bergamo
Bergamo, Bergamo, Italy
- University of Florence
Florence, IL, Italy
- University of San Martino
San Martino, Italy
- Regionala Etikprovningsnamnden Goteborg
Gothenburg, Sweden
- University of Illinois at Chicago
Chicago, Illinois, United States
- Johns Hopkins
Baltimore, Maryland, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- Ohio State Univesity
Columbus, Ohio, United States
- University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2007
- Primary completion
- 31 Aug 2011
- Completion
- 15 Jun 2015
- Last update posted
- 15 May 2017
- Registered enrollment
- 66
- Registry id
- NCT00572897
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.